José Alberto Ayala Ortiz, PVpharm CEO, will participate together with Andrea Álvarez, QPPV of FAES FARMA in a Round table and discussion about "Differences between Phase III and Phase IV Drug Safety and Pharmacovigilance" organized by the University of Valladolid. The conference will be held on 17th November 2022 at 18:00 CET, and it is free of access!! Please join here. https://forms.gle/FEDtVzLfZJfBxq448?fbclid=IwAR1eQx0ISwSau6DZmHZ-ZszE4-QJPcMpfm9wuXa2pMCinMTg0U8LGmTnQNo PVpharm is also organizing in-house trainings in pharmacovigilance for pharmaceutical companies and CROs, please contact us for further information.
José Ortiz will be participating as a trainer together with Marcela Fialova and Claire Longman, MSc Interim Head of GCP and Senior Pharmacovigilance Inspector at the Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom in the Pharmacovigilance System Master File (PSMF) course organized by DIA. The training will be delivered online from 1:00 PM to 5:00 PM (CEST) on November 2 to 3, 2022. This virtual live training course covers essential concepts and guidance about the Pharmacovigilance System Master File (PSMF). This key document describes the company’s pharmacovigilance system, supporting, and documenting its compliance with the requirements laid down…
José Ortiz, PVpharm CEO will participate one more time as a speaker in the next QPPV forum organized by DIA. You can find more information in the link: https://www.diaglobal.org/en/conference-listing/meetings/2022/11/global-forum-for-qualified-persons-for-pharmacovigilance-qppv José will be presenting in the Session 2: Pharmacovigilance System Oversight on 09 Nov 2022 9:00 AM – 09 Nov 2022 10:30 AM https://www.diaglobal.org/en/conference-listing/meetings/2022/11/global-forum-for-qualified-persons-for-pharmacovigilance-qppv/agenda/09/session-2-pharmacovigilance-system-oversight?ref=Session2PharmacovigilanceSystemOversight About the QPPV forum: In a changing and expanding world, this is still the only forum designed for QPPVs by QPPVs, now celebrating its 16th year and still going strong. Back in a face-to-face format, it brings together QPPVs from all over the world to discuss how…
José Ortiz will be participating as a trainer together with Wendy Huisman in the Pharmacovigilance Quality Management System course organized by DIA. The training will be delivered online from 9:00 AM to 01:30 PM (CEST) on September 19 to 22, 2022. The course will employ a mix of informative sessions, real case studies, and hands-on interactive exercises where attendees will be able to apply what they have learned. Learners will leave the course with an understanding of how elements of the Pharmacovigilance and Quality Management Systems fit together to achieve regulatory compliance. Course Highlights Quality and the Quality SystemQMS OverviewPV…
In the next edition (October 2022), PVpharm will not only participate as an exhibitor but also as a speaker, leading one of the conferences of this benchmark event.
PVpharm led the way in pharmacovigilance training by innovatively organizing another edition of its Pharmacovigilance Training. This 3rd edition was hosted on May, 2022.
PVpharm organizes its successful Pharmacovigilance Training. This 3rd edition will be hosted in Madrid on May 30 and 31, 2022, with the option of attending online.
The FUNGE will organize the XXVI Edition of the well-known "Pharmacovigilance for Healthcare Professionals" course. On this occasion, Jose Alberto Ayala Ortiz, CEO of PVpharm, will participate as a trainer.
This training will focus on explaining the mandatory data elements necessary for the electronic submission of information on medicinal products, applying the format of the eXtended EudraVigilance Product Report Message (XEVPRM) and the use of the XEVMPD data entry tool (EVWEB).
José Ortiz will be participating as a trainer in the next XEVMPD training on 14-16 Feb 2022. The training will focus on explaining the guidance and specifically the mandatory data elements necessary for the electronic submission of information on medicinal products.